Detalhe da pesquisa
1.
Antiretroviral Treatment-Induced Galectin-9 Might Impact HIV Viremia in Addition to Contributing to Inflammaging.
Int J Mol Sci;
24(15)2023 Jul 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37569647
2.
High IL-5 levels possibly contributing to HIV viremia in virologic non-responders at one year after initiation of anti-retroviral therapy.
Microb Pathog;
143: 104117, 2020 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32135221
3.
Possible role of plasma Galectin-9 levels as a surrogate marker of viremia in HIV infected patients on antiretroviral therapy in resource-limited settings.
AIDS Res Ther;
17(1): 43, 2020 07 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32678033
4.
Higher expression of human telomerase reverse transcriptase in productively-infected CD4 cells possibly indicates a mechanism for persistence of the virus in HIV infection.
Microbiol Immunol;
62(5): 317-326, 2018 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29577368
5.
Duplicate analysis method: a cheaper alternative to commercial IQC materials in limited resource settings for monitoring CD4 testing.
AIDS Res Ther;
12: 25, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26279667
6.
Pseudomembranous Type of Oral Candidiasis is Associated with Decreased Salivary Flow Rate and Secretory Immunoglobulin A Levels.
Mycopathologia;
180(1-2): 75-80, 2015 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25682023
7.
Differential modulation of phenotypic composition of HIV-infected and -uninfected PBMCs during cryopreservation.
J Immunoassay Immunochem;
34(4): 333-45, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23859784
8.
MiR-155 Negatively Regulates Anti-Viral Innate Responses among HIV-Infected Progressors.
Viruses;
15(11)2023 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38005883
9.
Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with COVID-19 associated mucormycosis.
Immunobiology;
228(3): 152384, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37071959
10.
Safety and Immunogenicity of SARS-CoV-2 Recombinant Spike Protein Vaccine in Children and Adolescents in India: A Phase 2-3 Randomized Clinical Trial.
JAMA Pediatr;
2023 Jul 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37523166
11.
Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study.
Lancet Reg Health Southeast Asia;
10: 100139, 2023 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36647543
12.
Both N- and C-terminal domains of galectin-9 are capable of inducing HIV reactivation despite mediating differential immunomodulatory functionalities.
Front Immunol;
13: 994830, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36569879
13.
Anti-HIV-1 ADCC and HIV-1 Env Can Be Partners in Reducing Latent HIV Reservoir.
Front Immunol;
12: 663919, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33995393
14.
Agreement between dried blood spots and HemoCue in Tamil Nadu, India.
Sci Rep;
11(1): 9285, 2021 04 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33927229
15.
A review on peripheral blood CD4+ T lymphocyte counts in healthy adult Indians.
Indian J Med Res;
132: 667-75, 2010 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21245613
16.
Safety & immunogenicity of tgAAC09, a recombinant adeno-associated virus type 2 HIV-1 subtype C vaccine in India.
Indian J Med Res;
132: 168-75, 2010 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20716817
17.
Urgent need for evaluating agonists of angiotensin-(1-7)/Mas receptor axis for treating patients with COVID-19.
Int J Infect Dis;
96: 348-351, 2020 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32389847
18.
Unsterile injection equipment associated with HIV outbreak and an extremely high prevalence of HCV-A case-control investigation from Unnao, India.
PLoS One;
15(12): e0243534, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33275646
19.
Elevated Levels of Galectin-9 but Not Osteopontin in HIV and Tuberculosis Infections Indicate Their Roles in Detecting MTB Infection in HIV Infected Individuals.
Front Microbiol;
11: 1685, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32765475
20.
Incomplete functional T-cell reconstitution in immunological non-responders at one year after initiation of antiretroviral therapy possibly predisposes them to infectious diseases.
Int J Infect Dis;
81: 114-122, 2019 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30658168